soul trial oral semaglutide cardiovascular outcomes nejm 2024 2025

soul trial oral semaglutide cardiovascular outcomes nejm 2024 2025 results Presented at ACC.25: Among participants SOUL: Oral Semaglutide Bests Usual – soul trial oral semaglutide cardiovascular

Name: soul trial oral semaglutide cardiovascular outcomes nejm 2024 2025 results Presented at ACC.25: Among participants SOUL: Oral Semaglutide Bests Usual – soul trial oral semaglutide cardiovascular
Brand: roaa.app
SKU: 28858919650
Price: 29.58 USD
Availability: InStock
Rating: 4.2034 (14 reviews)

SKU: 28858919650

4.2

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 11 - Aug 16

Description

They are a pill version of Wegovy manufactured by Novo Nordisk and, Foundayo, a tablet manufactured by Eli Lilly

2.4 Outcome definition The primary outcome was defined as major adverse cardiovascular events (a three-point composite of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke)